Key Finding:
In prostate cancer, Wnt signaling pathway alterations are enriched in metastatic tumors, and patients whose tumors harbor these alterations have a shorter overall survival following chemotherapy or hormonal therapy.
Publications
Characterization and impact of canonical Wnt signaling pathway (WSP) alterations on outcomes of metastatic prostate cancer.
– Caris Life Sciences
Download Publication